Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
139
NMPA:139
Drug Approvals
Doxapram Hydrochloride Injection
- Product Name
- 盐酸多沙普仑注射液
- Approval Number
- 国药准字H20093692
- Approval Date
- Jun 4, 2024
NMPA
Vecuronium Bromide for Injection
- Product Name
- 注射用维库溴铵
- Approval Number
- 国药准字H20084542
- Approval Date
- Dec 28, 2023
NMPA
Sodium Nitroprusside for Injection
- Product Name
- 注射用硝普钠
- Approval Number
- 国药准字H20084203
- Approval Date
- Jul 26, 2023
NMPA
Ramostron Hydrochloride for Injection
- Product Name
- 注射用盐酸雷莫司琼
- Approval Number
- 国药准字H20080715
- Approval Date
- Jul 26, 2023
NMPA
Olopatadine Hydrochloride Tablets
- Product Name
- 盐酸奥洛他定片
- Approval Number
- 国药准字H20223350
- Approval Date
- Feb 17, 2023
NMPA
Ambroxol Hydrochloride Granules
- Product Name
- 盐酸氨溴索颗粒
- Approval Number
- 国药准字H20130001
- Approval Date
- Jan 5, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
Clinical Trials
No trials found
News
No news found